Larry (Hua-xin) Liao, MD, PhD., is a Professor and Research Director of Human Vaccine Institute (DHVI) at Duke University. After graduation from the Shanghai Medical University, Dr. Liao started his research career working on the pathogenesis and vaccine development of epidemic hemorrhagic fever virus in the Institute of Virology in Beijing in early 1980s, then received his PhD. in biochemistry and molecular biology from University of North Carolina at Chapel Hill in 1991, joined the faculty as an Assistant Professor at Duke University in 1994 and became a full Professor in 2008. Dr. Liao is an expert in recombinant antibody technology, isolation of antibody genes from sorted or cultured single B cells and production of recombinant antibodies and proteins in mammalian cells by transient and stable transfection. Dr. Liao has published more than 140 peer-reviewed original papers and review articles, and his research is mainly focus on areas including HIV-1 vaccine immunogen design and development for induction of broadly reactive antibody and T cell responses; the host cellular and environmental factors that modulate HIV-host interaction; and B cell responses to pathogen infection and vaccination including HIV-1/SIV, influenza, dengue and other emerging and re-merging infections in humans and non-human primates.